Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Randomised placebo controlled trial of antihypertensive agents for the prevention of cardiovascular complications of hypertension
ISRCTN ISRCTN13275753
ClinicalTrials.gov identifier
Public title Randomised placebo controlled trial of antihypertensive agents for the prevention of cardiovascular complications of hypertension
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis That treatment with diuretic or beta-blocker in hypertensive people aged between 65 and 74 reduces risk of stroke, coronary heart disease and death.
Lay summary
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Hypertension
Participants - inclusion criteria Men and women aged 65-74 at recruitment in 226 general practices in the Medical Research Council's General Practice Research Framework. Systolic blood pressure 160-209 mmHg and diastolic pressure less than 115 mmHg.
Participants - exclusion criteria Secondary hypertension; already on antihypertensive treatment; accepted indication for antihypertensive treatment; myocardial infarction or stroke within previous three months; impaired renal function; presence of angina, intermittent claudication, diabetes, gout, bronchial asthma, serious intercurrent disease including malignant hypertension.
Anticipated start date 01/03/1982
Anticipated end date 01/03/1987
Status of trial Completed
Patient information material
Target number of participants 4396 participants
Interventions Amiloride, hydrochlorothiazide compared with placebo; atenolol compared with placebo.
Primary outcome measure(s) Stroke, coronary events, deaths from all causes.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (UK)
Trial website
Publications 1985 results in http://www.ncbi.nlm.nih.gov/pubmed/2861880
Contact name Prof  Tom  Meade
  Address Non-communicable Disease Epidemiology Unit
London School of Hygiene & Tropical Medicine
Keppel Street
  City/town London
  Zip/Postcode WC1E 7HT
  Country United Kingdom
  Email tom.meade@lshtm.ac.uk
Sponsor Sponsor not defined - Record provided by the Medical Research Council (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Email tom.meade@lshtm.ac.uk
Date applied 07/09/2005
Last edited 19/05/2011
Date ISRCTN assigned 08/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central